Healthcare Services

Peptide Synthesis Global Forecast: Market to Scale Up to $9.91 Billion by 2030 at 10.1% CAGR

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the peptide synthesis market from 2026–2035 with trusted insights from The Business Research Company

How much is the Peptide Synthesis Market valued at in 2026, and what valuation is forecast for 2030?

Over recent years, the peptide synthesis market size has experienced robust expansion. It is anticipated to increase from $6.18 billion in 2025 to reach $6.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. Historically, this growth has been fueled by factors such as the escalating demand for peptide-based therapeutics, advancements in solid-phase peptide synthesis, increased studies within academic and research institutes, the availability of high-purity reagents, and significant demand stemming from pharmaceutical R&D.

The peptide synthesis market is projected to experience substantial expansion over the coming years, reaching $9.91 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is fueled by several factors, including the rise of contract manufacturing and research services, the embrace of hybrid and recombinant peptide technologies, growing partnerships between biotechnology and pharmaceutical firms, the need for customized peptide synthesis, and developments in peptide characterization and analytical methods. Key trends anticipated within the forecast timeframe encompass the rising application of AI for peptide design and optimization, the broadening scope of precision medicine utilizing peptides, the incorporation of cloud and big data solutions for peptide research, the deployment of IoT-enabled laboratory instruments for live monitoring, and the establishment of smart manufacturing processes in peptide production.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

What Drivers Are Influencing The Growth Of The Peptide Synthesis Market?

The rising incidence of chronic illnesses is anticipated to fuel the expansion of the peptide synthesis market in the future. These conditions, also known as non-communicable diseases (NCDs), are long-lasting health issues that develop gradually and endure for an extended duration. Peptide synthesis offers a viable approach for chronic diseases, given that certain peptides exhibit anti-inflammatory and antioxidant properties, potentially assisting in the prevention of conditions like cardiovascular diseases. By targeting specific cellular processes and signaling pathways, peptides can tackle the root causes of chronic ailments, thereby introducing innovative therapeutic and management strategies. For example, in June 2025, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that noncommunicable diseases (NCDs) continue to be the primary cause of death and disability globally, including within the WHO European Region. In this region, 1 in 5 men and 1 in 10 women pass away before reaching 70 years of age due to NCDs like cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. Consequently, the increasing prevalence of chronic conditions is a significant factor propelling the expansion of the peptide synthesis market.

How Is The Peptide Synthesis Market Organized Into Various Segments?

The peptide synthesis market covered in this report is segmented –

1) By Product And Service: Reagents, Equipment, Services

2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology

3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

Subsegments:

1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents

2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers

3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services

Which Trends Are Expected To Influence The Peptide Synthesis Market In The Upcoming Years?

Key companies within the peptide synthesis market are directing their efforts towards the introduction of next-generation peptide synthesizers, like PurePep Sonata+, to secure a competitive edge. PurePep Sonata+ is an advanced peptide synthesizer noted for its superior efficiency, speed, and accuracy when contrasted with conventional peptide synthesizers. An example of this trend occurred in August 2025, when Vapourtec Ltd, a UK company focused on flow-chemistry instruments, unveiled the Peptide-Builder, a compact benchtop peptide synthesizer. The Peptide-Builder extends the capabilities of standard peptide synthesizers by incorporating Vapourtec’s Variable Bed Flow Reactor technology. This innovative approach supports continuous-flow solid-phase peptide synthesis, allowing for precise management of reaction conditions and enabling high-throughput synthesis for various peptide sequences. Furthermore, the system integrates automated software for sequence creation, streamlined coupling/deprotection protocols, and real-time tracking of resin volume and reaction progression, ensuring reliable and reproducible peptide production across diverse sequences and scales.

Who Are The Primary Competitors In The Global Peptide Synthesis Market?

Major companies operating in the peptide synthesis market are Thermo Fisher Scientific, Merck KGaA, Lonza Group, Kaneka Corporation, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Peptide Synthesis Market?

North America was the largest region in the peptide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Peptide Synthesis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13295&type=smp

Browse Through More Reports Similar to the Global Peptide Synthesis Market 2026, By The Business Research Company

Peptide Based Metabolic Disorders Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795